A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707).
JTCVS Open
; 4: 90-102, 2020 Dec.
Article
in En
| MEDLINE
| ID: mdl-36004301
CI, confidence interval; CSPOR, Comprehensive Support Project for Oncology Research; CT, computed tomography; DPD, dihydro-pyrimidine dehydrogenase; HR, hazard ratio; JCOG, Japan Clinical Oncology Group; N0, node-negative; NSCLC, nonsmall cell lung cancer; OS, overall survival; PET, positron emission tomography; RFS, relapse-free survival; S-1, tegafur/gimeracil/oteracil; UFT, tegafur/uracil; adjuvant chemotherapy; node-negative; nonsmall cell lung cancer; p-stage, pathologic stage; tegafur/gimeracil/oteracil; tegafur/uracil
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
JTCVS Open
Year:
2020
Document type:
Article
Affiliation country:
Japan
Country of publication:
Netherlands